Author: Kerecis Communications

Surgiclose

Medical-Fish-Skin Company Kerecis Expands Silicone Fish-Skin Combination Product Range for Surgical and Trauma Wound with SurgiClose® Silicone

Medicare Out-Patient Coverage for the Kerecis MariGen and Kerecis Shield Medical Fish-Skin Products

Fertram

Fertram Sigurjonsson and Kerecis Nominated for the European Inventor Award 2024

EWMA

Fertram Sigurjonsson, Founder and CEO of Kerecis, Receives the EWMA President’s Wound Care Entrepreneur of the Year Award

New Kerecis Medical-Fish-Skin Product Gets Quick Approval from Medicare Administrative Contractors

Kerecis GraftGuide

Kerecis to Donate FDA-Approved Fish-Skin for Burn Victims of Maui Wildfires

Ísafjörður

Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations

National Nurse Week

The Kerecis Beach Cleanup Initiative

The Kerecis Beach Cleanup Initiative

Nordic Scaleup Award

Kerecis, the Medical-Fish-Skin Company, Recognized for its Extraordinary Growth

Kerecis MariGen® Shield

Kerecis Combines Fish-Skin Graft and Silicone Cover for Wound Treatment

More Than 150 Million Americans Now Have Insurance Coverage for Kerecis’ Medical-Fish-Skin Wound Treatment

DAV 2023 – Deutschsprachige Arbeitsgemeinschaft für Verbrennungsmedizin

Kerecis Named One of Europe’s Fastest Growing Companies by Financial Times

Kerecis Named One of Europe’s Fastest Growing Companies by Financial Times

EWMA 2023 – European Wound Management Association

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.

Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.

Products

Company

Help

© 2010 – 2025 Kerecis. All Rights Reserved